Early Stage Researcher Seminar - Gro Vatne Røsland
Cancer research: Deregulation of mitochondrial function is crucial in the process of epithelial to mesenchymal transition
In 2014 Gro Vatne Røsland finished her PhD project in the field of neuro-oncology at Prof Rolf Bjerkvig´s group with Prof Hrvoje Miletic as
co-supervisor. During her PhD, Gro Vatne Røsland uncovered important aspects of the cancer specific oncogene epidermal growth factor receptor variant III (EGFRvIII) in glioblastoma. Sheis currently working as a postdoctoral fellow in a project collaboration between the mitochondrial research group headed by Prof Karl Johan Tronstad at the IBM and Prof Olav Dahl at the oncology department at Haukeland University Hospital.
She focuses at how the metabolic signature of cancer cells change when they become resistant to cancer therapy, with a specific focus on mitochondria. Specific metabolic enquiries can reveal alternative strategies to target cancer cells.